MyFinsight
Home
Blog
About
Mirum Pharmaceuticals, Inc. (MIRM)
Mirum Pharmaceuticals, Inc. (MIRM)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$5,822K
Free Cash flow
-$44,275K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of conver...
Stock-based compensation
Proceeds from maturities of inve...
Others
Negative Cash Flow Breakdown
Exchange and repurchase of 2029 ...
Purchase of investments
Net loss
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-67,227
-790,155
-5,730
2,905
Stock-based compensation
30,573
36,202
19,026
18,127
Depreciation and amortization
6,936
6,874
6,074
6,062
Amortization of debt discount and offering costs
658
454
436
443
Loss from termination of revenue interest purchase agreement
-
-
0
-
Non-cash interest expense related to the revenue interest liability
-
-
0
-
Unrealized foreign exchange loss (gain)
-896
-1,098
-193
643
Non-cash lease expense
595
550
457
447
Inventory reserves and firm commitment losses
0
0
0
-540
Fair value of common stock issued in connection with asset acquisition
0
415,271
-
-
Debt conversion inducement expense
11,678
-
-
-
Change in fair value of holdback liabilities
-12,158
998
-
-
Other
299
278
382
345
Accounts receivable
13,744
12,886
19,008
3,146
Prepaid and other current assets
1,084
6,630
-5,990
4,632
Inventory
-395
1,920
2,282
1,159
Other assets
5,835
4,796
1,637
2,684
Accounts payable, accrued expenses and other liabilities
-19,061
57,244
3,443
24,346
Holdback liabilities
-261
71,790
-
-
Operating lease liabilities
-630
-583
-513
-580
Net cash (used in) provided by operating activities
-44,252
-228,763
6,067
39,681
Purchase of investments
160,815
34,797
11,502
20,860
Proceeds from maturities of investments
25,847
33,892
13,108
18,820
Purchase of property and equipment
23
664
600
187
Cash paid for acquisition
-
-
0
-
Payments made for additions to intangible assets
25,000
10,000
0
0
Net cash used in investing activities
-159,991
-11,569
1,006
-2,227
Proceeds from issuance of convertible notes, net of issuance costs
672,435
-
-
-
Exchange and repurchase of 2029 convertible notes
474,365
-
-
-
Proceeds from issuance of common stock and pre-funded warrants in private placement, net of issuance costs
0
259,948
0
-
Proceeds from issuance of common stock in at-the-market offerings, net of issuance costs
-
-
0
-
Proceeds from issuance of convertible notes, net
-
-
0
-
Proceeds from issuance of common stock pursuant to equity plans
13,368
10,131
8,999
16,096
Payments of deferred offering costs
-
-
0
-
Payments on revenue interest liability
-
-
0
-
Net cash provided by financing activities
211,438
270,079
8,999
16,096
Effect of exchange rate on cash, cash equivalents and restricted cash
-1,373
-1,272
-408
349
Net increase in cash, cash equivalents and restricted cash
5,822
28,475
15,664
53,899
Cash, cash equivalents and restricted cash at beginning of period
326,640
298,165
282,501
222,928
Cash, cash equivalents and restricted cash at end of period
332,462
326,640
298,165
282,501
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
convertible notes, net of...
$672,435K
Proceeds from issuance of
common stock pursuant...
$13,368K
(-11.16%↓ Y/Y)
Net cash provided by
financing activities
$211,438K
(1305.18%↑ Y/Y)
Canceled cashflow
$474,365K
Net increase in
cash, cash...
$5,822K
(2.61%↑ Y/Y)
Canceled cashflow
$205,616K
Exchange and repurchase
of 2029...
$474,365K
Proceeds from maturities
of investments
$25,847K
(-39.18%↓ Y/Y)
Stock-based compensation
$30,573K
(-10.79%↓ Y/Y)
Change in fair value of
holdback liabilities
-$12,158K
Debt conversion
inducement expense
$11,678K
Depreciation and
amortization
$6,936K
(-42.72%↓ Y/Y)
Unrealized foreign
exchange loss (gain)
-$896K
(-170.55%↓ Y/Y)
Amortization of debt discount
and offering costs
$658K
(-23.49%↓ Y/Y)
Non-cash lease expense
$595K
(-27.97%↓ Y/Y)
Inventory
-$395K
(-107.89%↓ Y/Y)
Net cash used in
investing activities
-$159,991K
(-603.78%↓ Y/Y)
Net cash (used in)
provided by operating...
-$44,252K
(-539.05%↓ Y/Y)
Effect of exchange rate
on cash, cash...
-$1,373K
(-141.85%↓ Y/Y)
Canceled cashflow
$25,847K
Canceled cashflow
$63,889K
Purchase of investments
$160,815K
(147.17%↑ Y/Y)
Net loss
-$67,227K
(-227.33%↓ Y/Y)
Payments made for
additions to intangible...
$25,000K
Purchase of property and
equipment
$23K
(-86.23%↓ Y/Y)
Accounts payable,
accrued expenses and...
-$19,061K
(-185.42%↓ Y/Y)
Accounts receivable
$13,744K
(-46.94%↓ Y/Y)
Other assets
$5,835K
(334.80%↑ Y/Y)
Prepaid and other
current assets
$1,084K
(-84.76%↓ Y/Y)
Operating lease
liabilities
-$630K
(21.54%↑ Y/Y)
Other
$299K
(-55.64%↓ Y/Y)
Holdback liabilities
-$261K
Buy us a coffee